rs41300169
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001184880.2(PCDH19):āc.402C>Gā(p.Ile134Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000911 in 1,098,142 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001184880.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCDH19 | NM_001184880.2 | c.402C>G | p.Ile134Met | missense_variant | 1/6 | ENST00000373034.8 | NP_001171809.1 | |
PCDH19 | NM_001105243.2 | c.402C>G | p.Ile134Met | missense_variant | 1/5 | NP_001098713.1 | ||
PCDH19 | NM_020766.3 | c.402C>G | p.Ile134Met | missense_variant | 1/5 | NP_065817.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCDH19 | ENST00000373034.8 | c.402C>G | p.Ile134Met | missense_variant | 1/6 | 1 | NM_001184880.2 | ENSP00000362125 | A1 | |
PCDH19 | ENST00000255531.8 | c.402C>G | p.Ile134Met | missense_variant | 1/5 | 1 | ENSP00000255531 | P5 | ||
PCDH19 | ENST00000420881.6 | c.402C>G | p.Ile134Met | missense_variant | 1/5 | 1 | ENSP00000400327 | A1 |
Frequencies
GnomAD3 genomes Cov.: 25
GnomAD3 exomes AF: 0.00000551 AC: 1AN: 181650Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67492
GnomAD4 exome AF: 9.11e-7 AC: 1AN: 1098142Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 363504
GnomAD4 genome Cov.: 25
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 9 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 03, 2022 | This sequence change replaces isoleucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 134 of the PCDH19 protein (p.Ile134Met). This variant is present in population databases (no rsID available, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with PCDH19-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PCDH19 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at